treatment of celiac disease

... Magazzù G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disor- ders in Celiac Disease. Gastroenterology ... Prevalence of celiac disease in a sample of Turkish children and adoles- cents with type 1 diabetes mellitus. J Clin Gastroenterol 2006; 40: 655-7. 4. Tanure MG, Silva IN, Bahia M, et al. Prevalence of ... Development of ce- liac disease- associated antibodies in offspring of parents with type I diabetes. Diabetologia 2000; 43: 1005-11. 7. Jaeger C, Hatziagelaki E, Petzoldt R, et al. Comparative analysis of...

Ngày tải lên: 05/03/2014, 12:20

... Igs found in the serum of celiac disease patients. Keywords: autoimmunity; celiac disease; transglutaminase; epitope mapping; phage display. Celiac disease (CD) is a genetic disease strongly linked ... Greco, L. (1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology ... Schematic drawing of the cloning of 12 different tTG regions. Reference numbers of the amino acid residues at the ends of the cloned sequences are shown. Ó FEBS 2002 Epitope mapping of anti-tTG Igs...

Ngày tải lên: 08/03/2014, 09:20

Ngày tải lên: 20/06/2014, 07:20

... decreased risk of aging, chronic disease, or cancer chemopre- vention and treatment in the general population. 11.3 Parkinson’s Disease Parkinson’s disease (also known as Parkinson disease or PD) ... μmol of TE (Trolox equivalents)·g −1 of fresh weight (fwt), 131.2 mg·100 g −1 of fwt, and 319.3 mg·100 g −1 of fwt, respectively. The organic culture also produced fruit with higher contents of myricetin ... nor study subject can influ- ence, or bias, the assessment of the effect of the treatment on disease outcome. RCT study design features of particular importance include the following: an appropriate and...

Ngày tải lên: 25/10/2013, 05:20

... emerging targets for treatment of obesity and related metabolic diseases Tsuyoshi Kadomatsu, Mitsuhisa Tabata and Yuichi Oike Department of Molecular Genetics, Graduate School of Medical Sciences, ... with increased risk of cardiovascular disease, the leading cause of death. Therefore, it is important to understand the molecular basis underly- ing obesity and related metabolic diseases in order ... roles of ANGPTL2 and ANGPTL6 ⁄ AGF in obesity and related metabolic diseases, and discuss the possibility that both could func- tion as molecular targets for the prevention and treatment of obesity...

Ngày tải lên: 14/02/2014, 22:20

... Department of Medical Biophysics, University of Toronto, Canada 4 Department of Laboratory Medicine and Pathology, University of Toronto, Canada 5 Department of Biochemistry, University of Toronto, ... indicate the feasibility of using inhibition of MDR1 as an approach to the treatment of Fabry disease. Although the efficacy may not, as yet, be as dramatic as ERT, inhibition of MDR1 may prove most ... overnight with 2 mL of chloroform ⁄ methanol (2 : 1 v ⁄ v) per 100 lL of plasma and then partitioned against 1 ⁄ 5 volume of water. The lower phase was dried under a stream of nitrogen gas and...

Ngày tải lên: 19/02/2014, 07:20

... effectiveness of hydroxyurea treatment of hematologic diseases, the toxicity of hydroxyurea in the treatment of any disease, and the barriers to the treatment of sickle cell disease with hydroxyurea ... long-term harms of its use in patients with sickle cell disease and other diseases, and to discuss barriers to the use of hydroxyurea and other medications in the treatment of sickle cell disease. ... with Treatment for Patients with Sickle Cell Disease 61 Table 9. Summary of Barriers to Treatment of Sickle Cell Disease Reported by Patients and Providers 63 Table 10. Results of Studies...

Ngày tải lên: 05/03/2014, 10:20

... Collateralization of Striatofugal Neurons and Co-localization of Dopamine Receptors One of the important series of data that challenged the concept of segregated direct and indirect striatofugal pathways ... different parts of MD mostly related to posterior regions of the frontal lobe, including the frontal eye field areas of the premotor cortex (132). In rats, a lamellar organization of nigrofugal neurons ... development of dyskinesias after transient inactivation of small areas of the pallidum with the GABAergic agonist muscimol (178), over a wide range of injected concentra- tions and volumes of the...

Ngày tải lên: 05/03/2014, 23:20

... completion of 2 months of treatment, the continuation phase of treatment should consist of isoniazid and rifampin daily or twice weekly for 4 months to complete a total of 6 months of treatment. ... the strength of treatment recommendations based on quality of evidence* Strength of the recommendation A. Preferred; should generally be offered B. Alternative; acceptable to offer C. Offer when ... Management of Patients at Increased Risk of Relapse The result of a sputum culture at the conclusion of the ini- tial phase of treatment (2 months) has been shown to corre- late with the likelihood of...

Ngày tải lên: 06/03/2014, 04:20

... ameliorate several of the dysfunctional events characteristic of Alzheimer’s disease. Metal-based therapeutics have already provided promising results for the treatment of Alzheimer’s disease, and ... therapeutic strategy for the treatment of Alzheimer’s disease Peter J. Crouch 1 , Anthony R. White 1 and Ashley I. Bush 2,3 1 Department of Pathology and Centre for Neuroscience, The University of Melbourne, ... development of effective therapeutic strategies is hampered by a paucity of information on the biolo- gical mechanisms underlying the disease. The severity of AD relates to a multitude of age-related...

Ngày tải lên: 07/03/2014, 10:20

Ngày tải lên: 22/03/2014, 09:20

Ngày tải lên: 18/06/2014, 22:20

Ngày tải lên: 20/06/2014, 04:20

Ngày tải lên: 20/06/2014, 15:20